Capital Flow Monitor · Sponsors · CIK 2042705
Klothea Bio, Inc.
195 NW 40TH STREET, MIAMI, FL, 33127 · (305) 846-9027
Other Health Care · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$10.4M
Sold
$6.9M
% sold
66.3%
Investors
22
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | D/A ·current | 506(b) | $10.4M | $6.9M | 66.3% | 22 | EDGAR ↗ |
| 2026-05-28 | D/A | 506(b) | $10.4M | $5.9M | 57.1% | 18 | EDGAR ↗ |
| 2026-02-02 | D/A | 506(b) | $11.1M | $2.9M | 26.4% | 11 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Jeffrey B. Madden — Executive Officer / Director, Miami, FL
1 other raise
- ADvantage Therapeutics, Inc. $13.7M of $25.4M · 54.0%
-
Agustin Fernandez Santana III — Executive Officer / Director, Miami, FL
1 other raise
- ADvantage Therapeutics, Inc. $13.7M of $25.4M · 54.0%
-
Olivier Jarry — Executive Officer, Miami, FL
1 other raise
- OS Therapies Inc $5.0M of $10.0M · 50.0%
-
Walter Schmidt — Director, Miami, FL
1 other raise
- ADvantage Therapeutics, Inc. $13.7M of $25.4M · 54.0%
-
Petr Sramek — Director, Miami, FL
1 other raise
- Animal Biosciences, Inc. $2.3M of $2.6M · 88.9%
Placement agents
- Scott Hamilton Ryan · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.